Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline
Open Access
- 1 October 2000
- Vol. 84 (4) , 438-441
- https://doi.org/10.1136/heart.84.4.438
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Infective endocarditis: clinical spectrum, presentation and outcome. An analysis of 212 cases 1980-1995Heart, 2000
- Antiarrhythmics---from cell to clinic: past, present, and futureHeart, 2000
- Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failureThe American Journal of Cardiology, 1999
- Ventricular dilatation in the absence of ACE inhibitors: influence of haemodynamic and neurohormonal variables following myocardial infarctionHeart, 1999
- Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunctionThe American Journal of Cardiology, 1996
- Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedureJournal of Chromatography B: Biomedical Sciences and Applications, 1995
- Effect of Pentoxifylline on Apoptosis of Cultured CellsJournal of Cardiovascular Pharmacology, 1995
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.Proceedings of the National Academy of Sciences, 1990
- TNF-induced cardiomyopathyThe Lancet, 1990